A carregar...

Residual Tumor Index: A Prognostically Significant Pathologic Parameter in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma

In the setting of neoadjuvant therapy (NAT) for pancreatic adenocarcinoma (PDAC), accurate measurement of tumor size, and consequently, staging based on AJCC 8th edition, is difficult. Attempts to address the limitations of tumor size in the NAT setting have included correlation of residual tumor pe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Surg Pathol
Main Authors: Panni, Roheena Z., Gonzalez, Ivan, Hartley, Christopher P., Williams, Gregory A., Liu, Jingxia, Hawkins, William G., Chatterjee, Deyali
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756474/
https://ncbi.nlm.nih.gov/pubmed/30179901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000001144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!